CDK9 inhibitors, such as flavopiridol, SNS-032, and roscovitine, have been demonstrated to be efficient in cancer treatment through downregulation of these prosuvival and antiapoptotic proteins [16, 26, 35]. Here, CDK9 is linked to cancer.